These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 18020605

  • 1. Loteprednol etabonate: clinical potential in the management of ocular inflammation.
    Noble S, Goa KL.
    BioDrugs; 1998 Oct; 10(4):329-39. PubMed ID: 18020605
    [Abstract] [Full Text] [Related]

  • 2. Change in intraocular pressure during long-term use of loteprednol etabonate.
    Novack GD, Howes J, Crockett RS, Sherwood MB.
    J Glaucoma; 1998 Aug; 7(4):266-9. PubMed ID: 9713785
    [Abstract] [Full Text] [Related]

  • 3. A double-masked, placebo-controlled evaluation of the efficacy and safety of loteprednol etabonate in the treatment of giant papillary conjunctivitis. The Loteprednol Etabonate Giant Papillary Conjunctivitis Study Group I.
    Friedlaender MH, Howes J.
    Am J Ophthalmol; 1997 Apr; 123(4):455-64. PubMed ID: 9124242
    [Abstract] [Full Text] [Related]

  • 4. The conjunctival provocation test model of ocular allergy: utility for assessment of an ocular corticosteroid, loteprednol etabonate.
    Abelson M, Howes J, George M.
    J Ocul Pharmacol Ther; 1998 Dec; 14(6):533-42. PubMed ID: 9867336
    [Abstract] [Full Text] [Related]

  • 5. A randomized, double-masked, placebo-controlled parallel study of 0.2% loteprednol etabonate in patients with seasonal allergic conjunctivitis.
    Dell SJ, Lowry GM, Northcutt JA, Howes J, Novack GD, Hart K.
    J Allergy Clin Immunol; 1998 Aug; 102(2):251-5. PubMed ID: 9723669
    [Abstract] [Full Text] [Related]

  • 6. Impact of the Topical Ophthalmic Corticosteroid Loteprednol Etabonate on Intraocular Pressure.
    Sheppard JD, Comstock TL, Cavet ME.
    Adv Ther; 2016 Apr; 33(4):532-52. PubMed ID: 26984315
    [Abstract] [Full Text] [Related]

  • 7. A controlled evaluation of the efficacy and safety of loteprednol etabonate in the prophylactic treatment of seasonal allergic conjunctivitis. Loteprednol Allergic Conjunctivitis Study Group.
    Dell SJ, Shulman DG, Lowry GM, Howes J.
    Am J Ophthalmol; 1997 Jun; 123(6):791-7. PubMed ID: 9535623
    [Abstract] [Full Text] [Related]

  • 8. Loteprednol etabonate ophthalmic suspension 0.5 %: efficacy and safety for postoperative anti-inflammatory use.
    Amon M, Busin M.
    Int Ophthalmol; 2012 Oct; 32(5):507-17. PubMed ID: 22707339
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Attenuation of ocular hypertension with the use of topical loteprednol etabonate 0.5% in steroid responders after corneal transplantation.
    Holland EJ, Djalilian AR, Sanderson JP.
    Cornea; 2009 Dec; 28(10):1139-43. PubMed ID: 19770719
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A double-masked, placebo-controlled evaluation of the efficacy and safety of loteprednol etabonate in the treatment of giant papillary conjunctivitis.
    Asbell P, Howes J.
    CLAO J; 1997 Jan; 23(1):31-6. PubMed ID: 9001768
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Safety and tolerability of loteprednol etabonate 0.5% and tobramycin 0.3% ophthalmic suspension in pediatric subjects.
    Comstock TL, Paterno MR, Bateman KM, Decory HH, Gearinger M.
    Paediatr Drugs; 2012 Apr 01; 14(2):119-30. PubMed ID: 22292487
    [Abstract] [Full Text] [Related]

  • 16. A double-masked, placebo-controlled evaluation of 0.5% loteprednol etabonate in the treatment of postoperative inflammation. The Loteprednol Etabonate Postoperative Inflammation Study Group 2.
    Ophthalmology; 1998 Sep 01; 105(9):1780-6. PubMed ID: 9754192
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.